Impact of advanced lung cancer inflammation index on all-cause mortality among patients with heart failure: a systematic review and meta-analysis with reconstructed time-to-event data

Abstract Background Heart failure (HF) is associated with systemic inflammation and hypercatabolic syndrome, impacting body metabolism. The advanced lung cancer inflammation index (ALI) is a novel inflammatory and nutritional biomarker. We aimed to investigate the prognostic role of ALI in patients...

Full description

Saved in:
Bibliographic Details
Main Authors: Ahmed Mazen Amin, Ramy Ghaly, Hossam Elbenawi, Abdelrahman Ewis, Ubaid Khan, Khaled S. M. Elshaer, Mohamed Abuelazm, Basel Abdelazeem, Brijesh Patel, Farris K. Timimi, Islam Y. Elgendy
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Cardio-Oncology
Subjects:
Online Access:https://doi.org/10.1186/s40959-024-00295-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571248606969856
author Ahmed Mazen Amin
Ramy Ghaly
Hossam Elbenawi
Abdelrahman Ewis
Ubaid Khan
Khaled S. M. Elshaer
Mohamed Abuelazm
Basel Abdelazeem
Brijesh Patel
Farris K. Timimi
Islam Y. Elgendy
author_facet Ahmed Mazen Amin
Ramy Ghaly
Hossam Elbenawi
Abdelrahman Ewis
Ubaid Khan
Khaled S. M. Elshaer
Mohamed Abuelazm
Basel Abdelazeem
Brijesh Patel
Farris K. Timimi
Islam Y. Elgendy
author_sort Ahmed Mazen Amin
collection DOAJ
description Abstract Background Heart failure (HF) is associated with systemic inflammation and hypercatabolic syndrome, impacting body metabolism. The advanced lung cancer inflammation index (ALI) is a novel inflammatory and nutritional biomarker. We aimed to investigate the prognostic role of ALI in patients with HF. Methods We comprehensively searched PubMed, WOS, SCOPUS, EMBASE, and CENTRAL through October 2024. We conducted a pair-wise and prognostic systematic review and meta-analysis with a reconstructed time-to-event data meta-analysis. All analyses were performed using R V. 4.3.1. This meta-analysis was registered at PROSPERO (CRD42024535227). Results We included five studies with 2,795 patients. In the pair-wise meta-analysis, ALI ≤ 25 was significantly associated with an increased incidence of all-cause mortality compared with ALI > 25 (risk ratio [RR] 1.73, 95% confidence interval [CI] 1.36–2.21, P < 0.01). On the adjusted prognostic meta-analysis, higher ALI was significantly associated with a reduction in the risk of all-cause mortality (hazards ratio [HR] 0.45, 95% CI 0.35–0.58-, P < 0.01). The reconstructed Kaplan Meier showed that ALI > 25 was significantly associated with a 56% reduction in the risk of all-cause mortality compared with ALI ≤ 25 (HR 0.44, 95% CI 0.38–0.50, P < 0.000001). Conclusion Among patients with HF, a low ALI was associated with a higher incidence of all-cause mortality rate than those with a high ALI. These findings suggest that ALI can be used for prognostic stratification and aid clinical decision-making in HF management.
format Article
id doaj-art-8b02d3fce11b43408d902148d1855f9e
institution Kabale University
issn 2057-3804
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Cardio-Oncology
spelling doaj-art-8b02d3fce11b43408d902148d1855f9e2025-02-02T12:44:39ZengBMCCardio-Oncology2057-38042025-01-0111111210.1186/s40959-024-00295-1Impact of advanced lung cancer inflammation index on all-cause mortality among patients with heart failure: a systematic review and meta-analysis with reconstructed time-to-event dataAhmed Mazen Amin0Ramy Ghaly1Hossam Elbenawi2Abdelrahman Ewis3Ubaid Khan4Khaled S. M. Elshaer5Mohamed Abuelazm6Basel Abdelazeem7Brijesh Patel8Farris K. Timimi9Islam Y. Elgendy10Faculty of Medicine, Mansoura UniversityDepartment of Internal Medicine, University of Missouri-Kansas CityDepartment of Cardiovascular Medicine, Mayo ClinicFaculty of Medicine, Mansoura UniversityDivision of Cardiology, University of Maryland School of MedicineFaculty of Medicine, Alfaisal UniversityFaculty of Medicine, Tanta UniversityDepartment of Cardiology, West Virginia UniversityDepartment of Cardiology, West Virginia UniversityDepartment of Cardiovascular Medicine, Mayo ClinicDivision of Cardiovascular Medicine, Gill Heart Institute, University of KentuckyAbstract Background Heart failure (HF) is associated with systemic inflammation and hypercatabolic syndrome, impacting body metabolism. The advanced lung cancer inflammation index (ALI) is a novel inflammatory and nutritional biomarker. We aimed to investigate the prognostic role of ALI in patients with HF. Methods We comprehensively searched PubMed, WOS, SCOPUS, EMBASE, and CENTRAL through October 2024. We conducted a pair-wise and prognostic systematic review and meta-analysis with a reconstructed time-to-event data meta-analysis. All analyses were performed using R V. 4.3.1. This meta-analysis was registered at PROSPERO (CRD42024535227). Results We included five studies with 2,795 patients. In the pair-wise meta-analysis, ALI ≤ 25 was significantly associated with an increased incidence of all-cause mortality compared with ALI > 25 (risk ratio [RR] 1.73, 95% confidence interval [CI] 1.36–2.21, P < 0.01). On the adjusted prognostic meta-analysis, higher ALI was significantly associated with a reduction in the risk of all-cause mortality (hazards ratio [HR] 0.45, 95% CI 0.35–0.58-, P < 0.01). The reconstructed Kaplan Meier showed that ALI > 25 was significantly associated with a 56% reduction in the risk of all-cause mortality compared with ALI ≤ 25 (HR 0.44, 95% CI 0.38–0.50, P < 0.000001). Conclusion Among patients with HF, a low ALI was associated with a higher incidence of all-cause mortality rate than those with a high ALI. These findings suggest that ALI can be used for prognostic stratification and aid clinical decision-making in HF management.https://doi.org/10.1186/s40959-024-00295-1Advanced lung cancer inflammation indexHeart failureInflammationNutritionReviewAnalysis
spellingShingle Ahmed Mazen Amin
Ramy Ghaly
Hossam Elbenawi
Abdelrahman Ewis
Ubaid Khan
Khaled S. M. Elshaer
Mohamed Abuelazm
Basel Abdelazeem
Brijesh Patel
Farris K. Timimi
Islam Y. Elgendy
Impact of advanced lung cancer inflammation index on all-cause mortality among patients with heart failure: a systematic review and meta-analysis with reconstructed time-to-event data
Cardio-Oncology
Advanced lung cancer inflammation index
Heart failure
Inflammation
Nutrition
Review
Analysis
title Impact of advanced lung cancer inflammation index on all-cause mortality among patients with heart failure: a systematic review and meta-analysis with reconstructed time-to-event data
title_full Impact of advanced lung cancer inflammation index on all-cause mortality among patients with heart failure: a systematic review and meta-analysis with reconstructed time-to-event data
title_fullStr Impact of advanced lung cancer inflammation index on all-cause mortality among patients with heart failure: a systematic review and meta-analysis with reconstructed time-to-event data
title_full_unstemmed Impact of advanced lung cancer inflammation index on all-cause mortality among patients with heart failure: a systematic review and meta-analysis with reconstructed time-to-event data
title_short Impact of advanced lung cancer inflammation index on all-cause mortality among patients with heart failure: a systematic review and meta-analysis with reconstructed time-to-event data
title_sort impact of advanced lung cancer inflammation index on all cause mortality among patients with heart failure a systematic review and meta analysis with reconstructed time to event data
topic Advanced lung cancer inflammation index
Heart failure
Inflammation
Nutrition
Review
Analysis
url https://doi.org/10.1186/s40959-024-00295-1
work_keys_str_mv AT ahmedmazenamin impactofadvancedlungcancerinflammationindexonallcausemortalityamongpatientswithheartfailureasystematicreviewandmetaanalysiswithreconstructedtimetoeventdata
AT ramyghaly impactofadvancedlungcancerinflammationindexonallcausemortalityamongpatientswithheartfailureasystematicreviewandmetaanalysiswithreconstructedtimetoeventdata
AT hossamelbenawi impactofadvancedlungcancerinflammationindexonallcausemortalityamongpatientswithheartfailureasystematicreviewandmetaanalysiswithreconstructedtimetoeventdata
AT abdelrahmanewis impactofadvancedlungcancerinflammationindexonallcausemortalityamongpatientswithheartfailureasystematicreviewandmetaanalysiswithreconstructedtimetoeventdata
AT ubaidkhan impactofadvancedlungcancerinflammationindexonallcausemortalityamongpatientswithheartfailureasystematicreviewandmetaanalysiswithreconstructedtimetoeventdata
AT khaledsmelshaer impactofadvancedlungcancerinflammationindexonallcausemortalityamongpatientswithheartfailureasystematicreviewandmetaanalysiswithreconstructedtimetoeventdata
AT mohamedabuelazm impactofadvancedlungcancerinflammationindexonallcausemortalityamongpatientswithheartfailureasystematicreviewandmetaanalysiswithreconstructedtimetoeventdata
AT baselabdelazeem impactofadvancedlungcancerinflammationindexonallcausemortalityamongpatientswithheartfailureasystematicreviewandmetaanalysiswithreconstructedtimetoeventdata
AT brijeshpatel impactofadvancedlungcancerinflammationindexonallcausemortalityamongpatientswithheartfailureasystematicreviewandmetaanalysiswithreconstructedtimetoeventdata
AT farrisktimimi impactofadvancedlungcancerinflammationindexonallcausemortalityamongpatientswithheartfailureasystematicreviewandmetaanalysiswithreconstructedtimetoeventdata
AT islamyelgendy impactofadvancedlungcancerinflammationindexonallcausemortalityamongpatientswithheartfailureasystematicreviewandmetaanalysiswithreconstructedtimetoeventdata